Masaryk University Technology Transfer Office prepared an interview with Vitezslav Bryja about developing inhibitors of casein kinase 1 in collaboration with Kamil Paruch´s group (Department of Chemistry) that can be used in the future as treatment of chronic lymphocytic leukemia and potentially also of other diseases.
Read the interview here: https://www.ctt.muni.cz/en/news/interface/articles/i-peeked-into-a-world-that-was-hidden-to-me-says-vitezslav-bryja
Novinky pro říjen 2023 Milí studenti, kolegové a přátelé OFIŽ, se začátkem nového semestru se vracíme... Read More
Jménem organizační komise si Vás dovolujeme pozvat na XVIII. Myeloma and VI. Cell Therapy Workshop, jenž... Read More
Congratulations! High school student in our laboratory, Martin Zavřel has recently won the 1st place in biology category of... Read More
Abstract Polyglutamylation is a reversible posttranslational modification that is catalyzed by enzymes of the tubulin... Read More
Abstract: The migratory properties of leukemic cells are commonly associated with their pathological potential and... Read More
Začátkem září proběhla v prostorách našeho pracoviště Summer school of Developmental Biology. Letní škola zahrnovala... Read More